AllianzIM U.S. Large Cap Buffer10 Sep ETF SEPT 深 滬
已收盤 08-22 16:00:00 美东时间
33.4901
+0.350
+1.06%
華盛通- 最 高33.5399
- 今 開33.4601
- 成交量 1.14万股
- 最 低 33.4301
- 昨 收 33.14
- 總市值 1841.96万
- 52周最高 33.5399
- 市盈率 靜 --
- 換手率 2.08%
- 52周最低 25.54
- 委 比 -60.00%
- 總股本 55.00万
- 歷史最高 33.5399
- 量 比 25.46
- 振 幅 0.33%
- 歷史最低 23.42
- 每 手 1
- 風險率 1.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
Septerna, Inc. has initiated a Phase 1 clinical trial for SEP-631, a novel oral treatment targeting chronic spontaneous urticaria and mast cell-driven diseases. The trial aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SEP-631 in healthy volunteers. As a selective negative allosteric modulator of MRGPRX2, SEP-631 inhibits mast cell activation and degranulation, offering potential relief for millions affected b...
08-21 12:00
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Aug. 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) have opp...
08-15 00:00
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, July 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN) have oppo...
07-29 00:00
Septerna to Present at Jefferies Global Healthcare Conference
Septerna, Inc., a biotechnology company focused on GPCR drug discovery, announced that its CEO, Jeffrey Finer, will present at the Jefferies Global Healthcare Conference on June 5, 2025. A live webcast of the presentation will be available on the company’s website and will be archived for at least 30 days. Septerna’s proprietary Native Complex Platform™ enables the discovery of oral small molecule product candidates targeting endocrinology, immun...
05-29 12:00
SQM REPORTS EARNINGS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2024
Highlights SQM reported total revenues for the nine months ended September 30, 2024 of US$3,455.0 million compared to total revenues of US$6,155.9 million for the same period last year. Ne...
2024-11-20 21:00
Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results
– 14% year-over-year revenue increase from combined key growth drivers: Xywav®, Epidiolex® and Rylaze® – – 2024 total revenue guidance affirmed at $4.0 to $4.1 billion – – Zanidatamab 2L BTC...
2024-11-07 05:05
NACCO INDUSTRIES ANNOUNCES THIRD QUARTER 2024 RESULTS
Consolidated Q3 2024 Highlights: Operating profit of $19.7 million compared with Q3 2023 $6.3 million operating loss Q3 2024 includes $13.6 million of business interruption insurance income ...
2024-10-31 04:52
Whirlpool Announces Third-Quarter Results
-- Sequential margin expansion in MDA North America for the second consecutive quarter, driven by promotional pricing actions -- Q3 GAAP net earnings margin of 2.7% (Q2 5.5%); GAAP earning...
2024-10-24 04:05
Powerfleet Announces Strategic Acquisition of Fleet Complete
Expected to Create Industry Powerhouse with Total Revenue Anticipated to Exceed $400 Million Including $300+ Million of Recurring High Margin SaaS Revenue Highly Accretive with $200 Million ...
2024-09-18 19:00
SEASON TWO OF DORA, PARAMOUNT+'s ORIGINAL ANIMATED PRESCHOOL SERIES, PREMIERES FRIDAY, SEPT. 13
Season One of DORA Makes Its Linear Debut on Monday, Sept. 16, on Nickelodeon Dascha Polanco Joins Voice Cast as Season Two Guest Star Produced by Nickelodeon Animation, Season One of DO...
2024-08-05 23:00
